Please try another search
Hangzhou Tigermed Consulting Co., Ltd provides contract research organization services in the People’s Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers preclinical development services, including medicinal chemistry, compound screening, DMPK, safety and toxicology, bioanalytical, and formulation research and development services; and clinical development services, such as medical writing, clinical monitoring, regulatory affairs, data management and statistical analysis, clinical development strategy, site management, subject recruitment, medical device/ in vitro diagnostics, multi-region clinical trial, and vaccine clinical trial services. It also provides product market research, product marketing strategy, product finalization, product verification, registration strategy planning, marketing application, post-marketing supports, and product upgrade services. In addition, the company offers medical imaging, pharmacovigilance, medical translation, quality assurance, GMP consulting, central laboratories, functional services, EDC system, and call center services; and post-marketing clinical research solutions, such as site identification and selection, central monitoring, project team management, vendor management, and project management services. Hangzhou Tigermed Consulting Co., Ltd was incorporated in 2004 and is headquartered in Hangzhou, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Xiaoping Ye | 60 | 2010 | Co-Founder & Chairman |
Xiaochun Cao | 54 | 2010 | Co-Founder, GM & Executive Director |
Hao Wu | 56 | 2021 | Co-President & Executive Director |
Binghui Zhang | 61 | 2020 | Chairman of Supervisory Committee |
Zhimin Chen | 64 | 2017 | Shareholder Supervisor |
Zengyu Wen | 44 | 2017 | Executive VP, COO & Executive Director |
Kai Yu Liu | 55 | 2020 | Independent Non-Executive Director |
Yuwen Liu | - | 2024 | Independent Non-Executive Director |
Wenqing Lou | 32 | 2022 | Employee Representative Supervisor |
Huagang Yuan | 51 | 2023 | Independent Non Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review